December 12, 2005 – At the annual convention of the American Society of Hematology, numerous biotech companies have released data from clinical trials, including Genitope on its MyVax personalized cancer vaccine, BioCryst on Fodosine, Bioenvision on clofarabine, Seattle Genetics on SGN-30 and SGN-40, Immunomedics on its humanized anti-CD20 monoclonal antibody, Genta on Genasense, Amgen on Arenesp and AMG 531, Kosan on KOS-953, Vion on Cloretazine, and Lorus on GTI-2040. More details...
